Top

Gepubliceerd in:

2007 | OriginalPaper | Hoofdstuk

Diagnostiek bij hartfalen

Auteur : Dr. J. H. Cornel

Uitgeverij: Bohn Stafleu van Loghum

Abstract

Hartfalen is een klinisch syndroom dat wordt gekenmerkt door tekortschieten van de pompwerking van het hart, leidend tot een complex van klachten en verschijnselen. Om de tekortschietende circulatie op te vangen treden allerlei adaptatiemechanismen in werking, zoals activitatie van het renine-angiotensine-aldosteronsysteem en stijging van de natriuretische peptiden. Als bij gedegen anamnese en lichamelijk onderzoek de verdenking op de aanwezigheid van hartfalen ontstaat, is objectief bewijs van cardiale disfunctie (beeldvorming) nodig om het vermoeden van hartfalen te onderbouwen. Een verhoogde waarde van het natriuretisch peptide type B (BNP) ondersteunt de diagnose, maar is onvoldoende om de diagnose hartfalen te stellen. Bij de diagnostiek gaat het er overigens niet alleen om de correcte diagnose te stellen, maar ook om de oorzaak te achterhalen en om een indruk te krijgen van de ernst en de prognose. Al deze gegevens zijn van belang om de behandeling van hartfalen te optimaliseren.

vorige hoofdstuk Hartfalen: een systemische aandoening

volgende hoofdstuk Aritmie en Asynchronie Bij Hartfalen: Geneesmiddelen en Implantaten

Sutton MGSJ, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101:2981–8.PubMedCrossRef

Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161–72.PubMedCrossRef

Dantzig JM van, Delemarre BJ, Koster RW, Bot H, Visser CA. Pathogenesis of mitral regurgitation in acute myocardial infarction: importance of changes in left ventricular shape and regional function. Am Heart J 1996;131:865–71.PubMedCrossRef

Vasan RS, Benjamin EJ, Levy D. Congestive heart failure associated with normal left ventricular systolic function.Arch Intern Med 1996;156:146–57.PubMedCrossRef

Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European Society of Cardiology. Eur Heart J 2007, in press.

Brutsaert DL, De Keulenaer GW. Diastolic heart failure: a myth.. Curr Opin Cardiol 2006;21:240–8.PubMedCrossRef

Zile MR, Brutsaert DL. New concepts in diastolic disfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002;105:1387–93.PubMedCrossRef

Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344:17–22.PubMedCrossRef

Kitzman DW, Little WC, Brubaker PH, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144–50.PubMedCrossRef

10.

Maisel A, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161–7.PubMedCrossRef

11.

Multidisciplinaire richtlijn Chronisch hartfalen. Utrecht: CBO, 2002.

12.

Davie AP, Francis CM, Caruana L, et al. Assessing diagnosis in heart failure: which features are any use? QJM 1997;90:335–9.PubMedCrossRef

13.

Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease. Implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998;31:1002–10.PubMedCrossRef

14.

Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163–9.PubMedCrossRef

15.

Drazner MH, Rame JE, Stevenson LW, et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574–81.PubMedCrossRef

16.

Schiller N. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Circulation 1991;84(3 Suppl):I280-7.PubMed

17.

White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44–51.PubMedCrossRef

18.

Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561–6.PubMedCrossRef

19.

Dantzig JM van, Delemarre BJ, Bot H, Visser CA. Left ventricular thrombus in acute myocardial infarction. Eur Heart J 1996;17:1640–5.PubMedCrossRef

20.

Jong RM de, Cornel JH, Crijns HJGM, Veldhuisen DJ van. Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 2001;3:429–36.PubMedCrossRef

21.

Garcia MJ, Smedira NG, Greenberg NL, et al. Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: animal and human validation. J Am Coll Cardiol 2000;35:201–8.PubMedCrossRef

22.

Nakaoka H, Imitaka K, Amano M, Fujii J, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 1985;313:892–3.PubMedCrossRef

23.

Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005;330:625.PubMedCrossRef

24.

McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study. Circulation 2002;106:416–22.PubMedCrossRef

25.

Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic disfunction. The Framingham heart study. JAMA 2002;288:1252–9.

26.

Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934–41.PubMedCrossRef

27.

Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997;30:1758–64.PubMedCrossRef

28.

Shah MR, Hasselblad V, Gheorghiade M, et al. Prognostic usefulness of the sixminute walk in patients with advanced congestive heart failure secondary to ischemic or non ischemic cardiomyopathy. Am J Cardiol 2001;88:987–93.PubMedCrossRef

29.

Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778–86.PubMedCrossRef

Titel: Diagnostiek bij hartfalen
Auteur: Dr. J. H. Cornel
Uitgeverij: Bohn Stafleu van Loghum
Boek: Leerboek hartfalen
Print ISBN: 978-90-313-5022-3

Elektronisch ISBN: 978-90-313-6347-6

Copyright: 2007
DOI: https://doi.org/10.1007/978-90-313-6347-6_4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen